Irogue Igbinosa: Rethinking Iron Deficiency in Pregnancy with Intravenous Therapy
Irogue Igbinosa, Maternal Fetal Medicine Physician at Stanford University School of Medicine, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Obstetrics and Gynecology:
“Publication Alert, excited to share that our recent trial: Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial, was published recently.
Backstory: I’ve been working on since this trial since MFM (maternal fetal medicine fellow) fellowship.
Thankful for a team (Ijeoma Iwekaogwu, Elizabeth Sherwin, Stephanie Leonard, Deirdre Lyell and Caroline Berube) that helped from beginning to end.
Key Takeaway: Mild anemia in pregnancy should be treated and IV iron (ferumoxytol) should be considered as an option.”
Title: Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial
Authors: Irogue I Igbinosa, Stephanie A Leonard, Ijeoma Iwekaogwu, Elizabeth B Sherwin, Caroline Berube, Deirdre J Lyell
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring
-
Aug 11, 2026, 14:30Bharat Moyal: The New KDIGO 2026 Approach to Anemia in CKD
-
Aug 11, 2026, 14:16Rayan Ahmed: Master Blood Films and Pathology Online
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India